Literature DB >> 16428731

Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden.

Suganya Viriyakosol1, Michael A Matthias, Mark A Swancutt, Theo N Kirkland, Joseph M Vinetz.   

Abstract

The roles of innate immune responses in protection from or pathogenesis of severe leptospirosis remain unclear. We examined the role of Toll-like receptors (TLRs) in mouse infection and macrophage responses to Leptospira. C3H/HeJ mice (TLR4 deficient) and C3H/HeJ-SCID mice, but not C3H/OuJ mice (TLR4 intact), died after intraperitoneal infection with Leptospira interrogans serovar Icterohaemorrhagiae. Death in both C3H/HeJ mouse strains was associated with jaundice and pulmonary hemorrhage, similar to the patient from whom the isolate was obtained. In chronic sublethal infection, TLR4-deficient mice harbored more leptospires in liver, lung, and kidney than control mice. Heat-killed Leptospira stimulated macrophages to secrete proinflammatory cytokines, tumor necrosis factor alpha, interleukin-6, and macrophage inflammatory protein 2 not inhibited by polymyxin B, suggesting that leptospiral lipopolysaccharide (LPS) did not drive these responses. Anti-TLR4 and anti-MD-2 but not anti-CD14 monoclonal antibodies inhibited cytokine production. Peritoneal macrophages from CD14-/- and TLR2-/- mice exhibited no defect in cytokine responses to Leptospira compared to controls. Macrophages from C3H/HeJ, TLR4-/-, and MyD88-/- mice secreted far-lower levels of cytokines than wild-type macrophages in response to Leptospira. TLR4 plays a crucial role in protection from acute lethal infection and control of leptospiral burden during sublethal chronic infection. Cytokine responses in macrophages correlated with leptospiral clearance. These TLR4-dependent but CD14/TLR2-independent responses are likely mediated by a leptospiral ligand(s) other than LPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428731      PMCID: PMC1360355          DOI: 10.1128/IAI.74.2.887-895.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.

Authors:  C Werts; R I Tapping; J C Mathison; T H Chuang; V Kravchenko; I Saint Girons; D A Haake; P J Godowski; F Hayashi; A Ozinsky; D M Underhill; C J Kirschning; H Wagner; A Aderem; P S Tobias; R J Ulevitch
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 3.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

4.  Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.

Authors:  D A Haake; M K Mazel; A M McCoy; F Milward; G Chao; J Matsunaga; E A Wagar
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

Authors:  M Hirschfeld; J J Weis; V Toshchakov; C A Salkowski; M J Cody; D C Ward; N Qureshi; S M Michalek; S N Vogel
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona.

Authors:  B Adler; S Faine
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo.

Authors:  Steve D Swain; Sena J Lee; Michel C Nussenzweig; Allen G Harmsen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells.

Authors:  Gary R Klimpel; Michael A Matthias; Joseph M Vinetz
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

9.  Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis.

Authors:  Jarlath E Nally; Chavit Chantranuwat; Xiao-Yang Wu; Michael C Fishbein; Martha M Pereira; João José Pereira Da Silva; David R Blanco; Michael A Lovett
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

10.  Environmental exposure and leptospirosis, Peru.

Authors:  Michael A S Johnson; Hannah Smith; Priya Joeph; Robert H Gilman; Christian T Bautista; Kalina J Campos; Michelle Cespedes; Peter Klatsky; Carlos Vidal; Hilja Terry; Martiza M Calderon; Carlos Coral; Lilia Cabrera; Paminder S Parmar; Joseph M Vinetz
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more
  47 in total

Review 1.  Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses.

Authors:  Karen V Evangelista; Jenifer Coburn
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 2.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

3.  Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans.

Authors:  Frédérique Vernel-Pauillac; Fabrice Merien
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

Review 5.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

6.  Attenuated nephritis in inducible nitric oxide synthase knockout C57BL/6 mice and pulmonary hemorrhage in CB17 SCID and recombination activating gene 1 knockout C57BL/6 mice infected with Leptospira interrogans.

Authors:  Maurício Bandeira; Cleiton S Santos; Everton C de Azevedo; Luciane Marieta Soares; Júlio O Macedo; Samyra Marchi; Caroline Luane R da Silva; Adenizar D Chagas-Junior; Alan J A McBride; Flávia W C McBride; Mitermayer G Reis; Daniel A Athanazio
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

7.  Experimental Infection of Rattus norvegicus by the Group II Intermediate Pathogen, Leptospira licerasiae.

Authors:  Carla Fernandez; Aristea A Lubar; Joseph M Vinetz; Michael A Matthias
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 2.345

8.  Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany.

Authors:  Bodo Hoffmeister; Gabriele Peyerl-Hoffmann; Sven Pischke; Ines Zollner-Schwetz; Robert Krause; Matthias C Müller; Angelika Graf; Stefan Kluge; Gerd D Burchard; Winfried V Kern; Norbert Suttorp; Jakob P Cramer
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

9.  Toll-Like Receptor 2 Agonist Pam3CSK4 Alleviates the Pathology of Leptospirosis in Hamster.

Authors:  Wenlong Zhang; Naisheng Zhang; Xufeng Xie; Jian Guo; Xuemin Jin; Feng Xue; Zhuang Ding; Yongguo Cao
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

10.  The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses.

Authors:  Jeffrey M Jordan; Michael E Woods; Juan Olano; David H Walker
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.